Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7550971

Concept 2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
2022-01-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-918,919,000 JPY
594,696,000 JPY
Interest paid
-1,650,000 JPY
-2,954,000 JPY
Net cash provided by (used in) operating activities
-938,544,000 JPY
585,341,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-6,854,000 JPY
-57,614,000 JPY
Other, net
JPY
305,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-6,854,000 JPY
-57,309,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-59,994,000 JPY
-120,012,000 JPY
Redemption of bonds
-14,014,000 JPY
-14,014,000 JPY
Net cash provided by (used in) financing activities
1,222,158,000 JPY
166,348,000 JPY
Effect of exchange rate change on cash and cash equivalents
28,818,000 JPY
172,483,000 JPY
Net increase (decrease) in cash and cash equivalents
305,577,000 JPY
866,864,000 JPY
Cash and cash equivalents
3,684,625,000 JPY
3,379,048,000 JPY
4,684,699,000 JPY
3,817,834,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.